Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

Conditions

• Seborrheic Dermatitis

Interventions

• DRUG: Roflumilast Foam 0.3%
• DRUG: Vehicle foam

Sponsor

Arcutis Biotherapeutics, Inc.